Skip to main content

Myles Selig Wolf

Charles Johnson, M.D. Distinguished Professor of Medicine
Medicine, Nephrology

Selected Grants


Endocrinology and Metabolism Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

Identification of Host-Specific Determinants of APOL1-associated COVAN

ResearchAdvisor · Awarded by National Institutes of Health · 2024 - 2029

U2C/TL1 NC KUH TRIO Administrative Core

ResearchPreceptor · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028

Tissue-Specific Regulation and Effects of CYP24A1

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2027

Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23)

ResearchMentor · Awarded by National Institutes of Health · 2021 - 2026

Endocrinology and Metabolism Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029

Identification of Host-Specific Determinants of APOL1-associated COVAN

ResearchAdvisor · Awarded by National Institutes of Health · 2024 - 2029

U2C/TL1 NC KUH TRIO Administrative Core

ResearchPreceptor · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028

Tissue-Specific Regulation and Effects of CYP24A1

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2027

Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23)

ResearchMentor · Awarded by National Institutes of Health · 2021 - 2026

JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease

ResearchCo Investigator · Awarded by National Institute on Minority Health and Health Disparities · 2021 - 2026

Novel mechanisms underlying improved ischemic tolerance of female kidneys

ResearchCo-Sponsor · Awarded by American Heart Association · 2024 - 2025

"HiLo": Pragmatic trial of higher vs. lower serum phosphate targets in patients undergoing hemodialysis

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2025

Diet and Hypertension Management in Chronic Kidney Disease

ResearchAdvisor · Awarded by National Institutes of Health · 2019 - 2024

POSIBIL6 - Phase III

Clinical TrialPrincipal Investigator · Awarded by CSL Behring LLC · 2024 - 2024

The Role of Klotho and Serotonin in Cardiovascular Outcomes and Mortality in CKD

ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2021 - 2024

Duke CTSA (TL1) Year 5

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024

Metabolic regulation of pancreatitis

ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2024

A phase 2b/3 Randomized Clinical Trial of Clazakizumab in Patients with End Stage Kidney Disease Undergoing Dialysis

Clinical TrialPrincipal Investigator · Awarded by CSL Behring LLC · 2022 - 2023

Postdoctoral Training in Genomic Medicine Research

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2017 - 2023

Duke Training Grant in Nephrology

Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1995 - 2023

Targeting anti-ferroptotic pathways to prevent the AKI-to-CKD transition

FellowshipPrincipal Investigator · Awarded by American Heart Association · 2020 - 2021

Harnessing Antioxidative Stress Pathways in Renal Epithelial Progenitors to Prevent AKI-to-CKD Transition

ResearchMentor · Awarded by ASN Foundation for Kidney Research · 2019 - 2020

Pencast Videos to Boost Learning and Interest in Nephrology Among Internal Medicine Residents

ResearchMentor · Awarded by American Society of Nephrology · 2017 - 2020

Phosphate and FGF23: Dietary and Molecular Mediators of Health Disparities in Cardiovasular and Kidney Diseases (Center)

ResearchPrincipal Investigator · Awarded by Northwestern University · 2016 - 2020

Molecular Mechanisms of Cardiac Injury Induced by FGF23 in the Settings of High Phosphate Diet and CKD

ResearchPrincipal Investigator · Awarded by Northwestern University · 2016 - 2020

Role of FGF23 in Mineral Metabolism Across the Spectrum of Chronic Kidney Disease

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2019

FGF23 and Cardiovascular Disease in CKD (CRIC)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2019

Pilot Studies Targeting Mineral Metabolism in CKD

ResearchPrincipal Investigator · Awarded by Northwestern University · 2013 - 2019

Impact of phosphate and FGF23 reduction on intermediate end points in CKD

ResearchPrincipal Investigator · Awarded by Northwestern University · 2017 - 2019

Vitamin D Catabolism in Chronic Kidney Disease

ResearchPrincipal Investigator · Awarded by University of Washington · 2016 - 2019

FGF-23 and Clinical outcomes in ADPKD

ResearchPrincipal Investigator · Awarded by University of Colorado - Denver · 2016 - 2018

Mentored Patient-Oriented Research in Mineral Metabolism

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2017

External Relationships


  • Akebia
  • Alexion Pharmaceuticals, Inc. a subsidiary of AstraZeneca
  • Enyo
  • Jnana
  • Pharmacosmos
  • Akebia
  • Alexion Pharmaceuticals, Inc. a subsidiary of AstraZeneca
  • Enyo
  • Jnana
  • Pharmacosmos
  • Torii
  • Unicycive
  • Walden Biosciences

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.